HIV Research In Dallas
NTIDC Is One Of The Most Highly Respected Clinical Trial Sites For HIV/Aids Patients In The United States.
HIV Research in Dallas
NTIDC’s Research Department has participated in multiple trials for Antiretroviral drugs including the following:
- Protease Inhibitors
- Integrase Inhibitors
- Monoclonal Antibodies
- Entry Inhibitors
- Maturation Inhibitors
- Capsid Inhibitors
- Therapeutic Vaccine for HIV
NTIDC research department was developed in 2001 by Dr. Louis Sloan and Bryan King to provide access to latest cutting-edge treatments in HIV for our patients. We have conducted 100’s of clinical trials that helped bring the latest Antiretroviral treatments to market.
Our research team provides patients with a full spectrum of care including social work referrals, pharmacy support, standard of care and protocol required procedures.
Current Infectious Disease Clinical Trials
We are currently participating in Phases I, II, III and IV clinical trials for the study and treatment of HIV-infected individuals and are proud to offer our patients the latest experimental treatment options available.
Please contact Bryan King at email@example.com for information on our current studies.
STI/STD Treatment and Research in Dallas
NTIDC has established a reputation as one of the leading facilities for STI/STD treatment in Dallas, and our research department is one of the premier centers for the study and treatment of sexually transmitted infections in the United States.
NTIDC’s Research Department has participated in multiple trials for prevention and treatment of STI’s including the following:
- PreP or Pre-exposure prophylaxis
- HIV vaccine study for the prevention of HIV
- Shingles Vaccine for HIV infected subjects
Our on-site pharmacy provides our patients with convenient and confidential access to retail and specialty pharmaceuticals and clinical services. We also provide reimbursement services designed to assist our patients with insurance issues. We also offer overnight delivery in the Dallas metroplex as well as most cities in Texas and Oklahoma.